Predict Confirms Independence of Board Director as It Expands Med-Tech Footprint

An announcement from Predict S.P.A. Class B ( (IT:PRE) ) is now available.

Predict S.p.A., an innovative med-tech SME based in Bari with additional offices in Milan and Rome, operates across imaging, breath analysis, and digital healthcare, offering technologies like its Mistral breath-based diagnostic system, Aphel AI platform for robotic support, and Optip holopresence solutions for remote consultations and training. The company has built strong ties with leading Italian university hospitals and research institutes, reinforcing its role in cutting-edge healthcare technology.

The Board of Directors has completed its annual review and confirmed that Independent Director Vito Anelli continues to meet all legal and internal independence requirements, based on his disclosures and available public information. This confirmation supports Predict’s governance standards and regulatory compliance, providing reassurance to investors and stakeholders about the robustness of its oversight and corporate decision-making structures.

The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.40 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.

More about Predict S.P.A. Class B

Predict S.p.A. is an innovative Italian med-tech SME focused on in vivo diagnostics, distributing ultrasound and radiology equipment while developing advanced technologies in breath analysis and digital healthcare. Organized into four strategic business units spanning imaging support, breath diagnostics, augmented reality, and robotics, the company offers solutions such as the Mistral breath-analysis platform, the Aphel AI robotics system, and the Optip holopresence communication tools, and collaborates with major university hospitals and research institutes across Italy.

Average Trading Volume: 25,060

Technical Sentiment Signal: Sell

Current Market Cap: €5.72M

For an in-depth examination of PRE stock, go to TipRanks’ Overview page.